Senior Director, Small Molecule CMC Advisor (Analytical Development)
Takeda
Summary
We are seeking an experienced and visionary Senior Director, Small Molecule CMC Advisor to lead the analytical development strategy for our small molecule portfolio. In this high-impact leadership role, you will act as the analytical and CMC subject matter expert (SME) across cross-functional development teams, guiding programs from early-stage candidate selection through late-stage clinical trials and BLA/NDA registration. You will mentor and analytical team leaders on our project teams and strategically advise on AD project related initiatives to reduce development costs and accelerate timelines without compromising quality or compliance.
Job description
About the role
We are seeking an experienced and visionary Senior Director, Small Molecule CMC Advisor to lead the analytical development strategy for our small molecule portfolio. In this high-impact leadership role, you will act as the analytical and CMC subject matter expert (SME) across cross-functional development teams, guiding programs from early-stage candidate selection through late-stage clinical trials and BLA/NDA registration. You will mentor and analytical team leaders on our project teams and strategically advise on AD project related initiatives to reduce development costs and accelerate timelines without compromising quality or compliance.
How you will contribute
- Analytical Strategy & Leadership: Lead and execute comprehensive, phase-appropriate analytical development strategies for drug substances (API) and drug products.
- Talent Mentorship & Growth: Mentor, coach, and guide internal analytical development leaders and scientists, fostering professional growth, technical excellence, and strong project management capabilities.
- Strategic Speed & Cost Optimization: Proactively work with the Analytical Portfolio Leadership and Pharmascience Teams to design and execute strategic initiatives to streamline analytical workflows, reduce costs, and compress timelines to accelerate candidate molecules to clinic and market.
- Specifications & Control Strategies: Establish scientifically justified drug substance and drug product specifications based on batch history, clinical exposure, and stability data. Advise and mentor Analytical Development Team leaders on the development of a holistic control strategy.
- Regulatory Submissions: Author, review, and defend analytical CMC sections for global regulatory filings (IND/CTA, NDA/MAA) and respond directly to health authority inquiries.
- Quality & Investigations: Partner with Quality Assurance (QA) to manage Out-of-Specification (OOS) investigations, deviations, and CAPAs.
- Cross-Functional Collaboration: Act as senior AD advisor assisting the AD team to drive project alignment across project teams alongside Process Chemistry, Formulation, Regulatory Affairs, Quality, and Supply Chain.
Qualifications
- Education & Experience: Bachelors/ degree 25+ years relevant industry experience. Masters degree 21+ years relevant industry experience. PhD and 15+ years relevant industry experience.
- Leadership & Mentorship: Proven track record of successfully mentoring and elevating junior/mid-level analytical leaders or project managers.
- Business & Operational Acumen: Demonstrated capability to identify and resolve operational bottlenecks and implement successful cost-containment or timeline-acceleration initiatives within CMC models.
- Technical Expertise: Deep knowledge of cGMP regulations, ICH guidelines, and global health authority expectations (FDA, EMA) for small molecule development with technical expertise in synthetic molecules and oligosaccharides and/or peptides.
- Oversight Acumen: Proven track record in analytical development/ validation, stability program design and tech transfer as well as a strong knowledge of industry standard practices for nitrosamines, dissolution, solid form characterization, impurity identification and polymorph predication. Extensive experience driving analytical activities within a CMC team as either an Analytical Representative or CMC lead.
Requirements
- Bachelors degree and 25+ years relevant industry experience
- Masters degree and 21+ years relevant industry experience
- PhD and 15+ years relevant industry experience
- Proven track record of successfully mentoring and elevating junior/mid-level analytical leaders or project managers
- Demonstrated capability to identify and resolve operational bottlenecks and implement successful cost-containment or timeline-acceleration initiatives within CMC models
- Deep knowledge of cGMP regulations, ICH guidelines, and global health authority expectations (FDA, EMA) for small molecule development
- Technical expertise in synthetic molecules and oligosaccharides and/or peptides
- Proven track record in analytical development/validation, stability program design and tech transfer
- Strong knowledge of industry standard practices for nitrosamines, dissolution, solid form characterization, impurity identification and polymorph prediction
- Extensive experience driving analytical activities within a CMC team as either an Analytical Representative or CMC lead
Company overview
Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company founded in 1781 and incorporated in 1925. As one of the world's top 20 largest pharmaceutical companies by revenue and the third largest in Asia, Takeda specializes in developing and commercializing innovative medicines across several therapeutic areas including oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies, and vaccines. With approximately 49,095 employees globally, the company operates research and development centers, manufacturing facilities, and commercial operations across 39 U.S. states and numerous countries worldwide. Takeda maintains dual headquarters in Tokyo and Osaka, Japan, with significant operations in Cambridge, Massachusetts, where it serves as the largest life sciences employer in the state. The company's patient-focused approach is guided by its Takeda-ism values of Integrity, Fairness, Honesty, and Perseverance, emphasizing a commitment to delivering life-transforming treatments while advancing sustainable healthcare solutions. Takeda's extensive portfolio includes both innovative biologics and small molecule drugs, supported by strategic acquisitions and partnerships that have expanded its capabilities in areas such as immuno-oncology and rare disease treatments.